Literature DB >> 2337112

Pneumococcal meningitis during intravenous ciprofloxacin therapy.

J Righter1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2337112     DOI： 10.1016/0002-9343(90)90442-g

Source DB:  PubMed          Journal:  Am J Med        ISSN： 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  6 in total

Review 1.  Potential interactions of the extended-spectrum fluoroquinolones with the CNS.

Authors:  H Lode
Journal:  Drug Saf       Date:  1999-08       Impact factor: 5.606

2.  Comparative bactericidal activities of ciprofloxacin, clinafloxacin, grepafloxacin, levofloxacin, moxifloxacin, and trovafloxacin against Streptococcus pneumoniae in a dynamic in vitro model.

Authors:  M E Klepser; E J Ernst; C R Petzold; P Rhomberg; G V Doern
Journal:  Antimicrob Agents Chemother       Date:  2001-03       Impact factor: 5.191

3.  Pharmacodynamic comparisons of levofloxacin, ciprofloxacin, and ampicillin against Streptococcus pneumoniae in an in vitro model of infection.

Authors:  M K Lacy; W Lu; X Xu; P R Tessier; D P Nicolau; R Quintiliani; C H Nightingale
Journal:  Antimicrob Agents Chemother       Date:  1999-03       Impact factor: 5.191

4.  Ciprofloxacin: an oral quinolone for the treatment of infections with gram-negative pathogens. Committee on Antimicrobial Agents. Canadian Infectious Disease Society.

Authors:  T J Louie
Journal:  CMAJ       Date:  1994-03-01       Impact factor: 8.262

Review 5.  Activity of quinolones against gram-positive cocci: clinical features.

Authors:  H Giamarellou
Journal:  Drugs       Date:  1995       Impact factor: 9.546

Review 6.  Guide to selection of fluoroquinolones in patients with lower respiratory tract infections.

Authors:  Wael E Shams; Martin E Evans
Journal:  Drugs       Date:  2005       Impact factor: 9.546
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.